-1-pentylindole.svg)
| |
| Names | |
|---|---|
|
Preferred IUPAC name
[4-(Hydroxymethyl)phenyl](1-pentyl-1H-indol-3-yl)methanone | |
| Identifiers | |
3D model (
JSmol)
|
|
| ChemSpider | |
PubChem
CID
|
|
| UNII | |
| |
| |
| Properties | |
| C21H23NO2 | |
| Molar mass | 321.420 g·mol−1 |
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
| |
3-(4-Hydroxymethylbenzoyl)-1-pentylindole is a synthetic cannabinoid. It is planned to be scheduled (in group I-N) in Poland. [1] It has been reported to the EMCDDA and Europol for the first time in 2010 [2] under the terms of European Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances. [3]
See also
References
- ^ http://www.mz.gov.pl/wwwmz/index?mr=q491&ms=382&ml=pl&mi=382&mx=0&mt=&my=131&ma=030747 http://www.mz.gov.pl/wwwfiles/ma_struktura/docs/ustawa_narkoman_201209171553.pdf Archived 2015-12-22 at the Wayback Machine "[E]kspertyza [opracowana] przez Katedrę i Zakład Farmakologii Doświadczalnej i Klinicznej Warszawskiego Uniwersytetu Medycznego [...] potwierdziła zasadność objęcia kontrolą ustawową [...] syntetycznych kanabinoidów: JWH-015, JWH-098, JWH-251, JWH-307, AM-2201, 3-(4-hydroksymetylobenzoilo)-1-pentyloindol" ("Department of Experimental and Clinical Pharmacology of Medical University of Warsaw evaluated that synthetic cannabinoids JWH-015, JWH-098, JWH-251, JWH-307, AM-2201, 3-(4-hydroxymethylbenzoyl)-1-pentylindole need to be scheduled.", accessed 30 April 2013)
- ^ "Annex 2 – New psychoactive substances reported to the EMCDDA and Europol for the first time in 2010 under the terms of Council Decision 2005/387/JHA" (PDF). European Monitoring Centre for Drugs and Drug Addiction.
- ^ "32005D0387 - EN - EUR-Lex: European Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances". EUR-Lex (in Afrikaans). 2005-05-10. Retrieved 2021-11-24.
|
| |
| Names | |
|---|---|
|
Preferred IUPAC name
[4-(Hydroxymethyl)phenyl](1-pentyl-1H-indol-3-yl)methanone | |
| Identifiers | |
3D model (
JSmol)
|
|
| ChemSpider | |
PubChem
CID
|
|
| UNII | |
| |
| |
| Properties | |
| C21H23NO2 | |
| Molar mass | 321.420 g·mol−1 |
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
| |
3-(4-Hydroxymethylbenzoyl)-1-pentylindole is a synthetic cannabinoid. It is planned to be scheduled (in group I-N) in Poland. [1] It has been reported to the EMCDDA and Europol for the first time in 2010 [2] under the terms of European Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances. [3]
See also
References
- ^ http://www.mz.gov.pl/wwwmz/index?mr=q491&ms=382&ml=pl&mi=382&mx=0&mt=&my=131&ma=030747 http://www.mz.gov.pl/wwwfiles/ma_struktura/docs/ustawa_narkoman_201209171553.pdf Archived 2015-12-22 at the Wayback Machine "[E]kspertyza [opracowana] przez Katedrę i Zakład Farmakologii Doświadczalnej i Klinicznej Warszawskiego Uniwersytetu Medycznego [...] potwierdziła zasadność objęcia kontrolą ustawową [...] syntetycznych kanabinoidów: JWH-015, JWH-098, JWH-251, JWH-307, AM-2201, 3-(4-hydroksymetylobenzoilo)-1-pentyloindol" ("Department of Experimental and Clinical Pharmacology of Medical University of Warsaw evaluated that synthetic cannabinoids JWH-015, JWH-098, JWH-251, JWH-307, AM-2201, 3-(4-hydroxymethylbenzoyl)-1-pentylindole need to be scheduled.", accessed 30 April 2013)
- ^ "Annex 2 – New psychoactive substances reported to the EMCDDA and Europol for the first time in 2010 under the terms of Council Decision 2005/387/JHA" (PDF). European Monitoring Centre for Drugs and Drug Addiction.
- ^ "32005D0387 - EN - EUR-Lex: European Council Decision 2005/387/JHA of 10 May 2005 on the information exchange, risk-assessment and control of new psychoactive substances". EUR-Lex (in Afrikaans). 2005-05-10. Retrieved 2021-11-24.